NPI Details
Amber Khan, M.D is an internal medicine in Houston, TX with 23 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Amber Khan, M.D NPI is 1811108475. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
2222 GREENHOUSE RD, BLDG 800
THE HOUSTON RHEUMATOLOGY CENTER
HOUSTON, TX
ZIP 77084
Phone: (281) 851-7088
Fax: (281) 422-7177
The NPI 1811108475 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
- Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
- Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
- Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Injection of additional new drug or substance into vein (HCPCS:96375)
- Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
The enumeration date for this NPI number is 5/25/2007 and was last updated on 3/15/2016.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 57011842 | OHIO | Yes |
